Advances and advantages of nanomedicine in the pharmacological targeting of hyaluronan-CD44 interactions and signaling in cancer. (Q38235803)
Jump to navigation
Jump to search
scientific article published on January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Advances and advantages of nanomedicine in the pharmacological targeting of hyaluronan-CD44 interactions and signaling in cancer. |
scientific article published on January 2014 |
Statements
Advances and advantages of nanomedicine in the pharmacological targeting of hyaluronan-CD44 interactions and signaling in cancer (English)
Spyros S Skandalis
Chrisostomi Gialeli
Achilleas D Theocharis